Litcius/Paper detail

SARS-CoV-2: the “Uncensored” Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon

Pietro Gentile

2021Aging and Disease25 citationsDOIOpen Access PDF

Abstract

In this second return of the pandemic, January 2021, it appears to be clear that a Nano-sized organism, the SARS-CoV-2, has rendered the human race helpless, made the global health status decline, and drowned the world economy. However, it does not appear clear the real origin of the SARS-CoV-2 and the aim of this work is to report and discuss, maybe for the first time since the pandemic began, the scientific data published in this specific field, analyzing the potentially available weapons against the SARS-CoV-2. About this last point, a ray of hope comes from the potential of Mesenchymal Stem Cells (MSCs) that has already been established in Coronavirus Disease 2019 (COVID-19), and in particular from the Adipose-Derived Mesenchymal Stem Cells (AD-MSCs). However, cell-based therapy has its own limits, especially represented by the know-how in this field and by the rules of applications. It was suggested a biological therapy using AD-MSCs as a weapon against COVID-19, as they can be a game-changer owing to their immuno-modulatory nature, which combats the cytokine storm characterizing this disease, and their practical efficiency, which will realistically aid large access to therapy worldwide.

Topics & Concepts

Cytokine stormMesenchymal stem cellPandemicCoronavirus disease 2019 (COVID-19)Stem cellGlobal healthDiseaseMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Adipose tissueVirologyInternet privacyImmunologyBiologyInfectious disease (medical specialty)Computer sciencePublic healthPathologyCell biologyEndocrinologyMesenchymal stem cell researchLong-Term Effects of COVID-19Extracellular vesicles in disease
SARS-CoV-2: the “Uncensored” Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon | Litcius